Pharma & Biotech

The biotechnology sector is no stranger to dramatic price swings, but Century Therapeutics is currently weathering an exceptionally severe downturn....

Viking Therapeutics shares registered substantial double-digit gains late last week, propelled by favorable sector developments and sustained bullish sentiment among...

After an impressive rally, Medpace shares are showing initial signs of fatigue. The clinical research organization's stock closed Friday's session...

While ClearPoint Neuro's stock experienced a minor decline in Friday's trading session, substantial institutional investors are demonstrating pronounced bullish sentiment....

Biotechnology firm Arvinas is undergoing a significant strategic pivot, marked by a comprehensive restructuring plan that has placed its shares...

Reviva Pharmaceuticals Holdings Inc. witnessed a sharp decline in its share price after unveiling plans to raise $9 million through...

Syndax Pharmaceuticals stands at a pivotal juncture, with a significant regulatory decision for its flagship cancer therapy scheduled for late...

Shares of Viking Therapeutics experienced substantial gains following the release of impressive Phase 2 trial results for its oral formulation...

Altimmune finds itself navigating turbulent waters as multiple class-action lawsuits cast a shadow over the company's stock performance. The litigation...

Pulse Biosciences, a prominent biotechnology firm, experienced significant volatility as a wave of insider selling activity followed a period of...